Solanigroside G

Details

Top
Internal ID 6072d698-b1e0-404d-8a25-b8df55fa5aac
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins
IUPAC Name (2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(1R,2S,3R,4R,5'R,6R,7S,8R,9S,12S,13S,16S,18S)-3-hydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
SMILES (Canonical) CC1CCC2(C(C3C(O2)C(C4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)CO)O)OC9C(C(C(CO9)O)O)O)OC2C(C(C(C(O2)CO)O)O)O)O)O)C)C)O)C)OC1
SMILES (Isomeric) C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)[C@@H]([C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)C)C)O)C)OC1
InChI InChI=1S/C50H82O23/c1-19-7-12-50(65-17-19)20(2)29-41(73-50)34(58)30-23-6-5-21-13-22(8-10-48(21,3)24(23)9-11-49(29,30)4)66-45-39(63)36(60)40(28(16-53)69-45)70-47-43(72-46-38(62)35(59)32(56)26(14-51)67-46)42(33(57)27(15-52)68-47)71-44-37(61)31(55)25(54)18-64-44/h19-47,51-63H,5-18H2,1-4H3/t19-,20+,21+,22+,23-,24+,25-,26-,27-,28-,29+,30-,31+,32-,33-,34-,35+,36-,37-,38-,39-,40+,41-,42+,43-,44+,45-,46+,47+,48+,49-,50-/m1/s1
InChI Key HVSIYDVSJUTGKS-BWKOVPGSSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C50H82O23
Molecular Weight 1051.20 g/mol
Exact Mass 1050.52468886 g/mol
Topological Polar Surface Area (TPSA) 355.00 Ų
XlogP -1.30
Atomic LogP (AlogP) -3.30
H-Bond Acceptor 23
H-Bond Donor 13
Rotatable Bonds 11

Synonyms

Top
CHEMBL448027

2D Structure

Top
2D Structure of Solanigroside G

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.5246 52.46%
Caco-2 - 0.8782 87.82%
Blood Brain Barrier - 0.6750 67.50%
Human oral bioavailability - 0.7429 74.29%
Subcellular localzation Mitochondria 0.6174 61.74%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8867 88.67%
OATP1B3 inhibitior + 0.9480 94.80%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior + 0.6250 62.50%
BSEP inhibitior + 0.7561 75.61%
P-glycoprotein inhibitior + 0.7341 73.41%
P-glycoprotein substrate + 0.5000 50.00%
CYP3A4 substrate + 0.7520 75.20%
CYP2C9 substrate - 0.8054 80.54%
CYP2D6 substrate - 0.8164 81.64%
CYP3A4 inhibition - 0.9473 94.73%
CYP2C9 inhibition - 0.9215 92.15%
CYP2C19 inhibition - 0.8997 89.97%
CYP2D6 inhibition - 0.9561 95.61%
CYP1A2 inhibition - 0.9215 92.15%
CYP2C8 inhibition + 0.6780 67.80%
CYP inhibitory promiscuity - 0.9616 96.16%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.6223 62.23%
Eye corrosion - 0.9917 99.17%
Eye irritation - 0.9058 90.58%
Skin irritation - 0.6555 65.55%
Skin corrosion - 0.9521 95.21%
Ames mutagenesis - 0.7154 71.54%
Human Ether-a-go-go-Related Gene inhibition + 0.8225 82.25%
Micronuclear - 0.9100 91.00%
Hepatotoxicity - 0.8875 88.75%
skin sensitisation - 0.9420 94.20%
Respiratory toxicity + 0.7556 75.56%
Reproductive toxicity + 0.7000 70.00%
Mitochondrial toxicity - 0.5375 53.75%
Nephrotoxicity - 0.8856 88.56%
Acute Oral Toxicity (c) I 0.8185 81.85%
Estrogen receptor binding + 0.8502 85.02%
Androgen receptor binding + 0.7122 71.22%
Thyroid receptor binding - 0.5379 53.79%
Glucocorticoid receptor binding + 0.5768 57.68%
Aromatase binding + 0.6393 63.93%
PPAR gamma + 0.7458 74.58%
Honey bee toxicity - 0.5296 52.96%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity + 0.5100 51.00%
Fish aquatic toxicity + 0.7523 75.23%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.68% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 97.32% 91.11%
CHEMBL3137262 O60341 LSD1/CoREST complex 96.18% 97.09%
CHEMBL233 P35372 Mu opioid receptor 94.68% 97.93%
CHEMBL218 P21554 Cannabinoid CB1 receptor 94.54% 96.61%
CHEMBL253 P34972 Cannabinoid CB2 receptor 93.57% 97.25%
CHEMBL237 P41145 Kappa opioid receptor 93.49% 98.10%
CHEMBL1994 P08235 Mineralocorticoid receptor 91.79% 100.00%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 91.19% 95.50%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 90.99% 89.05%
CHEMBL226 P30542 Adenosine A1 receptor 90.82% 95.93%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 89.73% 96.77%
CHEMBL6136 O60341 Lysine-specific histone demethylase 1 89.41% 95.58%
CHEMBL5255 O00206 Toll-like receptor 4 87.46% 92.50%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 87.35% 94.45%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 85.74% 91.24%
CHEMBL241 Q14432 Phosphodiesterase 3A 85.10% 92.94%
CHEMBL4618 P09960 Leukotriene A4 hydrolase 84.23% 97.86%
CHEMBL3922 P50579 Methionine aminopeptidase 2 83.93% 97.28%
CHEMBL3880 P07900 Heat shock protein HSP 90-alpha 83.19% 96.21%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 82.57% 100.00%
CHEMBL3892 Q99500 Sphingosine 1-phosphate receptor Edg-3 82.27% 97.29%
CHEMBL3430907 Q96GD4 Aurora kinase B/Inner centromere protein 82.18% 97.50%
CHEMBL2955 O95136 Sphingosine 1-phosphate receptor Edg-5 81.73% 92.86%
CHEMBL3476 O15111 Inhibitor of nuclear factor kappa B kinase alpha subunit 81.28% 95.83%
CHEMBL5608 Q16288 NT-3 growth factor receptor 81.28% 95.89%
CHEMBL1075162 Q13304 Uracil nucleotide/cysteinyl leukotriene receptor 80.65% 80.33%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 80.40% 95.89%
CHEMBL206 P03372 Estrogen receptor alpha 80.38% 97.64%

Cross-Links

Top
PubChem 16083120
NPASS NPC204025
LOTUS LTS0178527
wikiData Q105034411